BACM
AGN

Blue Arrow Capital Management’s Allergan plc AGN Stock Holding History

Blue Arrow Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,753
Closed -$4.09M – 196
2015
Q1 		$4.09M Buy
+13,753
New +$3.92M 0.4% 72
2014
Q3 		– Sell
-336
Closed -$75K – 225
2014
Q2 		$75K Sell
336
-496
-60% -$103K 0.01% 137
2014
Q1 		$171K Buy
+832
New +$165K 0.03% 106

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Blue Arrow Capital Management's AGN Position: Q2 2015 in Review

Blue Arrow Capital Management sold out of Allergan plc (AGN) in Q2 2015, closing a stake of 13,753 shares — an estimated $4.09M sold.

Blue Arrow Capital Management first reported a position in AGN in Q1 2014 and held it in 3 quarters. The position peaked at $4.09M in Q1 2015. 1,036 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Blue Arrow Capital Management reported no remaining Allergan plc position as of Q2 2015 after selling out during the quarter.
  • Blue Arrow Capital Management sold 13,753 Allergan plc shares in Q2 2015, an estimated $4.09M.
  • Blue Arrow Capital Management first reported a position in Allergan plc in Q1 2014 and held it in 3 quarters.
  • Blue Arrow Capital Management's Allergan plc position peaked at $4.09M in Q1 2015.
  • 1,036 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Blue Arrow Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.